🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The hypotension defined as 20 % less than the basal SBP (systolic blood pre...
Status
Completed
Location
Hospital Germans Trias i Pujol
Start Date
2013-05
Trial ID
NCT01891175
ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharm...
Status
Completed
Location
Frontage Clinical Services
Start Date
2020-02-17
Trial ID
NCT04220801
Treatments Being Tested
This trial is divided into two parts, a dose-escalation study (phase 1) and...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2013-08
Trial ID
NCT01933815
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
The purpose of the study is to investigate the safety, tolerability, and pr...
Status
Unknown
Location
Urologie Planegg
Start Date
2020-07-07
Trial ID
NCT04819399
Treatments Being Tested
To compare the efficacy and tolerability of levofloxacin-based sequential t...
Status
Unknown
Location
National Taiwan University Hospital, Hsinchu Branch
Start Date
2012-02
Trial ID
NCT01537055
Treatments Being Tested
The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-08-27
Trial ID
NCT02428309
Treatments Being Tested
This project aims to study the expression of clock genes and related protei...
Status
Enrolling By Invitation
Location
Affiliated Hospital of Nanjing University of Chinese Medicine
Start Date
2024-09-30
Trial ID
NCT06601452
Treatments Being Tested
The primary purpose of this first-in-man study is to investigate whether a ...
Status
Completed
Location
Investigator Site
Start Date
2016-02-01
Trial ID
NCT02702648
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested